Gamida Cell Bounces Back With Omisirge US Approval

For Use In Hematological Malignancies

 
• By Ayisha Sharma
  
Stem Cells, 3D rendering. - Illustration
Omisirge Makes Use Of Gamida's NAM Technology • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip